Top 10 evidence-based essentials in pulmonology
A structured framework of guidelines, trials, therapies, and tools used in clinical practice.
By
MDSpire News Staff
September 29, 2026
Clinical Scorecard: Top 10 evidence-based essentials in pulmonology
At a Glance
Category Detail
Condition Pulmonary diseases
Key Mechanisms Clinical guidelines, randomized trials, therapeutic advances, risk assessment tools
Target Population Patients with respiratory conditions such as asthma, COPD, pulmonary fibrosis, pulmonary hypertension, and ARDS
Care Setting Pulmonary medicine
Key Highlights
GINA and GOLD reports provide updated management strategies for asthma and COPD. Conditional recommendations for idiopathic pulmonary fibrosis treatment include transbronchial lung cryobiopsy. Dupilumab shows reduced exacerbations in COPD patients with high eosinophil counts. Updated ARDS guidelines recommend corticosteroids and ECMO for severe cases. Ensifentrine approved as maintenance therapy for COPD.
Guideline-Based Recommendations
Diagnosis
Revised hemodynamic definitions and classification for pulmonary hypertension. Updated diagnostic algorithms for COPD and ARDS.
Management
Conditional recommendations against antacid therapy for idiopathic pulmonary fibrosis. Use of neuromuscular blockers for early severe ARDS.
Monitoring & Follow-up
BODE index for assessing mortality risk in COPD patients.
Risks
Higher BODE index scores correlate with greater mortality risk.
Patient & Prescribing Data
Adults with moderate to severe COPD and asthma patients aged 12 years or older.
Dupilumab and mepolizumab reduce exacerbations in COPD; ensifentrine improves lung function.
Clinical Best Practices
Implement updated vaccination recommendations for COPD management. Utilize evidence-based guidelines for the treatment of pulmonary hypertension.
Related Resources & Content